Breaking News Instant updates and real-time market news.

IBM

IBM

$143.07

-0.47 (-0.33%)

17:31
07/17/19
07/17
17:31
07/17/19
17:31

IBM says gross margins expanded across its portfolio in Q2

Says will return to targeted leverage ratios "within a couple of years" after suspending share repurchases following Red Hat acquisition closing on July 9th. Comments taken from Q2 earnings conference call.

  • 17

    Jul

  • 18

    Jul

IBM IBM
$143.07

-0.47 (-0.33%)

06/06/19
DADA
06/06/19
NO CHANGE
Target $9
DADA
Buy
Cloudera price target lowered to $9 from $23 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on Cloudera (CLDR) to $9 after its "disastrous" quarter with a reset of the company's recurring revenue expectations, resignation of its CEO, and weak bookings, as customers await the release of Cloudera Data Platform, or CDP. The analyst also points to Cloudera's higher churn, and increased competitiveness from Amazon's (AMZN) AWS, Microsoft's (MSFT) Azure, and Google's (GOOGL) GCP impacting the quarter. Jaluria cuts his FY21 EPS view to (19c) from 22c but maintains his Buy rating on Cloudera, citing his "glimmer of hope" that the company can reaccelerate growth with CDP or that either a private equity firm or IBM (IBM) would acquire it given the reduced 1.8-times enterprise value to expected 2020 revenue valuation.
06/21/19
WBLR
06/21/19
DOWNGRADE
WBLR
Market Perform
Red Hat downgraded to Market Perform from Outperform at William Blair
William Blair analyst Jason Ader downgraded Red Hat (RHT) to Market Perform from Outperform citing the nearing of the takeover by IBM (IBM).
06/21/19
NEED
06/21/19
NO CHANGE
NEED
Hold
Red Hat acquisition by IBM 'well on track', says Needham
Needham analyst Jack Andrews kept his Hold rating on Red Hat (RHT) after its Q1 earnings beat that was helped in part by the tax benefits from merger-related costs, saying the company's growth in its Infrastructure business has remained strong and its large-deal metrics were "solid". The analyst notes that while the company made no further updates on its pending IBM (IBM) acquisition, its recent approval by the DOJ and speculation of "unconditional" approval by E.U. regulators suggest that the completion of the deal remains "well on track".
07/09/19
STFL
07/09/19
NO CHANGE
Target $169
STFL
Buy
Red Hat closing probably earlier than most expected, says Stifel
Stifel analyst David Grossman said IBM's (IBM) closing of its Red Hat (RHT) acquisition probably came earlier than most expected, adding that IBM will report standalone Q2 results next week, on July 17, and than will provide an update including Red Hat on a webcast scheduled for August 2. IBM is set up as a defensive holding with two potential catalysts, namely continued improvement in its core infrastructure services business and demonstrated success in leveraging Red Hat, said Grossman, who keeps a Buy rating and $169 price target on IBM shares.

TODAY'S FREE FLY STORIES

TREE

LendingTree

$317.86

3.4 (1.08%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 13

    Nov

  • 19

    Nov

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

, EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Hot Stocks
EQT Midstream Partners-owned MVP says project work will be 90% complete by 2020 »

Mountain Valley announced…

EQM

EQT Midstream Partners

$32.99

-0.2 (-0.60%)

EQT

EQT Corporation

$9.54

-0.175 (-1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 05

    Nov

SNN

Smith & Nephew

$43.65

-4.165 (-8.71%)

07:48
10/22/19
10/22
07:48
10/22/19
07:48
Recommendations
Smith & Nephew analyst commentary  »

Smith & Nephew CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMC

Vulcan Materials

$146.64

0.5 (0.34%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Initiation
Vulcan Materials initiated  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BBIO

BridgeBio

$18.54

0.29 (1.59%)

07:47
10/22/19
10/22
07:47
10/22/19
07:47
Hot Stocks
BridgeBio announces presentation of data from subsidiaries studies »

BridgeBio Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEL

TE Connectivity

$93.74

0.885 (0.95%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Initiation
TE Connectivity initiated  »

TE Connectivity initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

MBRX

Moleculin Biotech

$1.07

-0.005 (-0.47%)

07:45
10/22/19
10/22
07:45
10/22/19
07:45
Hot Stocks
Moleculin Biotech raises Annamycin production »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEP

NextEra Energy Partners

$51.04

-0.54 (-1.05%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Earnings
Breaking Earnings news story on NextEra Energy Partners »

NextEra Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 04

    Dec

AX

Axos Financial

$29.97

0.54 (1.83%)

07:43
10/22/19
10/22
07:43
10/22/19
07:43
Hot Stocks
Newbridge Securities enters five-year clearing agreement with Axos Clearing »

Newbridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 29

    Oct

  • 06

    Nov

  • 04

    Dec

  • 05

    Dec

CVA

Covanta

$17.06

0.31 (1.85%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Downgrade
Covanta rating change  »

Covanta double downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

APH

Amphenol

$100.40

1.35 (1.36%)

07:42
10/22/19
10/22
07:42
10/22/19
07:42
Initiation
Amphenol initiated  »

Amphenol initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

MAIN

Main Street

$42.50

0.23 (0.54%)

07:41
10/22/19
10/22
07:41
10/22/19
07:41
Downgrade
Main Street rating change  »

Main Street downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

, OPK

Opko Health

$2.12

0.03 (1.44%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Recommendations
Ascendis Pharma, Opko Health, Pfizer analyst commentary  »

Ascendis Pharma price…

ASND

Ascendis Pharma

$103.39

4.25 (4.29%)

OPK

Opko Health

$2.12

0.03 (1.44%)

PFE

Pfizer

$36.45

-0.01 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Dec

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:40
10/22/19
10/22
07:40
10/22/19
07:40
Hot Stocks
Callon Petroleum files presentation highlighting benefits of Carrizo deal »

Callon Petroleum Company…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

BAND

Bandwidth

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Bandwidth rating change  »

Bandwidth upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ARCC

Ares Capital

$18.70

0.14 (0.75%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Downgrade
Ares Capital rating change  »

Ares Capital downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

FRPT

Freshpet

$49.68

0.05 (0.10%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Upgrade
Freshpet rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 19

    Nov

  • 20

    Nov

CHCO

City Holding

$79.30

1.94 (2.51%)

07:39
10/22/19
10/22
07:39
10/22/19
07:39
Earnings
City Holding reports Q3 EPS $1.36, consensus $1.32 »

Reports Q3 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCC

Owl Rock

$16.90

-0.08 (-0.47%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Downgrade
Owl Rock rating change  »

Owl Rock downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

, CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Hot Stocks
Paulson & Co. reiterates opposition to Carrizo deal »

Paulson & Co., as…

CPE

Callon Petroleum

$3.71

-0.12 (-3.13%)

CRZO

Carrizo Oil & Gas

$7.29

-0.18 (-2.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 14

    Nov

  • 14

    Nov

LMT

Lockheed Martin

$373.16

0.54 (0.14%)

07:38
10/22/19
10/22
07:38
10/22/19
07:38
Hot Stocks
Lockheed Martin sees FY20 sales $62.0B, consensus $62.82B »

The company said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

RVNC

Revance

$15.67

0.495 (3.26%)

07:37
10/22/19
10/22
07:37
10/22/19
07:37
Conference/Events
Revance management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 21

    Nov

AAOI

Applied Optoelectronics

$10.83

-0.02 (-0.18%)

07:37
10/22/19
10/22
07:37
10/22/19
07:37
Downgrade
Applied Optoelectronics rating change  »

Applied Optoelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 09

    Dec

ZION

Zions Bancorp

$45.68

0.96 (2.15%)

07:36
10/22/19
10/22
07:36
10/22/19
07:36
Recommendations
Zions Bancorp analyst commentary  »

Zions Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBIX

Ebix

$39.90

1.32 (3.42%)

07:35
10/22/19
10/22
07:35
10/22/19
07:35
Hot Stocks
Ebix facilitates $20B of premiums for Willis Accounting over last four years »

Ebix Europe announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.